Of note, since it has been reported that loss-of-function variants of PCSK9 are associated with low circulating levels of LDL cholesterol (LDL-C) and a reduced risk of coronary artery disease (47), our results suggest a function of CASP11 in promoting LCL-C by enhancing PCSK9. Here, PCSK9 is linked to coronary artery disorder.